Suitability of propofol-remifentanil pharmacodynamic interaction model
Not Applicable
- Conditions
- gynecological disease
- Registration Number
- JPRN-UMIN000028961
- Lead Sponsor
- Asahikawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
height<150cm, weight<40kg, BMI>30, during pregnancy, during lactation, take antipsychotic drug, severe heart and/or renal failure, vasopressors in the operation, continuous unstable hemodynamic parameter (sBP>200mmHg, sBP<80mmHg, HR<40bpm)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The effect site concentrations of propofol and remifentanil(Loss of consiousness, insertion of a laryngoscopy, recovery of consiousness)
- Secondary Outcome Measures
Name Time Method Blood pressure, Heart rate, The noxious stimulus response index (Loss of consiousness, insertion of a laryngoscopy, recovery of consiousness)